Literature DB >> 10843741

Interleukin 6 promotes vasculogenesis of murine brain microvessel endothelial cells.

D Fee1, D Grzybicki, M Dobbs, S Ihyer, J Clotfelter, S Macvilay, M N Hart, M Sandor, Z Fabry.   

Abstract

Interleukin 6 (IL-6) is a cytokine that acts on a wide range of tissues influencing cell growth and differentiation. Here we show that IL-6 plays a role in the early vascular development (vasculogenesis) in the central nervous system (CNS). We report that IL-6 induces the proliferation of brain microvascular endothelial cells in vitro. Furthermore, IL-6 significantly accelerates the formation of tube-like structures by these cells in Matrigel basement matrix. Moreover, IL-6 mRNA is expressed in vivo in two physiological conditions in which vascularization in the CNS is important: (1) during normal brain development, (2) during the healing process of a traumatic brain injury. Expression of IL-6 mRNA coincides with the expression of vascular endothelial growth factor (VEGF) mRNA in the developing brain with decreasing expression following birth. However, IL-6 mRNA can be detected in the healing adult murine brain tissue by in situ hybridization coinciding with the period of intense tissue reorganization. The transient upregulation of IL-6 mRNA during normal brain development and at brain injury site and the effect of IL-6 on in vitro vasculogenesis suggest that IL-6 may play a role in normal physiology of vascularization in the CNS. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10843741     DOI: 10.1006/cyto.1999.0599

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  27 in total

1.  Engineering macrophages to control the inflammatory response and angiogenesis.

Authors:  K V Eaton; H L Yang; C M Giachelli; M Scatena
Journal:  Exp Cell Res       Date:  2015-11-21       Impact factor: 3.905

2.  Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine.

Authors:  Monique B Nilsson; Robert R Langley; Isaiah J Fidler
Journal:  Cancer Res       Date:  2005-12-01       Impact factor: 12.701

3.  Neural transmembrane protease and endothelial Gs protein activation in cell contact-dependent signaling between neural stem/progenitor cells and brain endothelial cells.

Authors:  Hsiu-Hui Tung; Sheau-Ling Lee
Journal:  J Biol Chem       Date:  2012-05-10       Impact factor: 5.157

Review 4.  A lifespan approach to neuroinflammatory and cognitive disorders: a critical role for glia.

Authors:  Staci D Bilbo; Susan H Smith; Jaclyn M Schwarz
Journal:  J Neuroimmune Pharmacol       Date:  2011-08-06       Impact factor: 4.147

5.  CREB-binding protein silencing inhibits thrombin-induced endothelial progenitor cells angiogenesis.

Authors:  Hong Jiang; Si-si Chen; Jian Yang; Jing Chen; Bo He; Li-hua Zhu; Lang Wang
Journal:  Mol Biol Rep       Date:  2011-06-14       Impact factor: 2.316

6.  Reduced hippocampal neurogenesis in adult transgenic mice with chronic astrocytic production of interleukin-6.

Authors:  Luc Vallières; Iain L Campbell; Fred H Gage; Paul E Sawchenko
Journal:  J Neurosci       Date:  2002-01-15       Impact factor: 6.167

7.  Trans-signaling is a dominant mechanism for the pathogenic actions of interleukin-6 in the brain.

Authors:  Iain L Campbell; Maria Erta; Sue Ling Lim; Ricardo Frausto; Ulrike May; Stefan Rose-John; Jürgen Scheller; Juan Hidalgo
Journal:  J Neurosci       Date:  2014-02-12       Impact factor: 6.167

8.  Lipocalin-7 is a matricellular regulator of angiogenesis.

Authors:  Leslie J Brown; Mariam Alawoki; Mary E Crawford; Tiffany Reida; Allison Sears; Tory Torma; Allan R Albig
Journal:  PLoS One       Date:  2010-11-09       Impact factor: 3.240

Review 9.  Fetal alcohol spectrum disorders and neuroimmune changes.

Authors:  Paul D Drew; Cynthia J M Kane
Journal:  Int Rev Neurobiol       Date:  2014       Impact factor: 3.230

10.  Complement C3 and C5 play critical roles in traumatic brain cryoinjury: blocking effects on neutrophil extravasation by C5a receptor antagonist.

Authors:  Diane L Sewell; Brendon Nacewicz; Frances Liu; Sinarack Macvilay; Anna Erdei; John D Lambris; Matyas Sandor; Zsuzsa Fabry
Journal:  J Neuroimmunol       Date:  2004-10       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.